Abstract
Novel 1-phenoxy-3-(piperazin-1-yl)propan-2-ol derivatives were designed and synthesized as potential triple reuptake inhibitors, which simultaneously inhibit serotonin, norepinephrine, and dopamine transporters (SERT, NET, and DAT, respectively). Through neurotransmitter transporter uptake assays, inhibitory activities of 1-phenoxy-3-(piperazin-1-yl)propan-2-ol derivatives were evaluated. We discovered compound 19 exhibited the most potent inhibitory activities against all three monoamine neurotransmitter transporters and the IC50 values of 19 against SERT, NET, and DAT were determined. In addition, binding modes of 19 with SERT, NET, and DAT were predicted by docking studies.
Original language | English |
---|---|
Pages (from-to) | 596-599 |
Number of pages | 4 |
Journal | Bulletin of the Korean Chemical Society |
Volume | 44 |
Issue number | 7 |
DOIs | |
Publication status | Published - 2023 Jul |
Bibliographical note
Publisher Copyright:© 2023 Korean Chemical Society, Seoul & Wiley-VCH GmbH.
Keywords
- antidepressants
- aryloxypropanolpiperazine
- major depressive disorder
- monoamine neurotransmitter
- triple reuptake inhibitor
ASJC Scopus subject areas
- General Chemistry